Haemophilus Influenzae Type b Conjugate Vaccine, MAS-Hib VAC ®
MAS-Hib VAC®️, Haemophilus Influenzae Type b (Hib) Conjugate Vaccine,
MAS-Hib VAC®️, Haemophilus Influenzae Type b (Hib) Conjugate Vaccine, is the homogeneous and sterile suspension of Haemophilus influenza Type b PRP (Capsular polysaccharide, polyribosyl ribitol phosphate) conjugated with tetanus toxoid (HibPRP-TT). The vaccine is produced as a adsorbed on aluminum phosphate in suitable carrier. Highly purified PRP of Hib bacteria and highly purified tetanus toxoid employed for preparation of this product. Each freeze-dried vial of MAS-Hib VAC®️ contain highly purified Hib PRP as active ingredient, and aluminum phosphate as a adjuvant. In infants and young children (under 5 years of age), Hib causes dangerous infectious diseases bacteremia and acute bacterial meningitis. Occasionally, it causes epiglottitis (obstructive laryngitis), cellulitis, osteomyelitis, and joint infections. This vaccine is indicated, in infants from 2 months, for the prevention of invasive diseases such as meningitis, septicemia, epiglottitis… caused by Haemophilus influenza type b bacteria. MAS-Hib VAC®️ is used for routine active immunization in infants aged 2 to 59 months. MAS-Hib VAC®️ is available in 3ml freeze dried vial as single dose.
This vaccine has numerus following advantages :
- Effective and safe immunity against different infectious disease due to Hib bacteria
- Rapid and potent immunogenicity
- High quality of product according to international standards